VIRAMUNE 50 mg/5 ml, oral suspension bottle, 240 ml
Active ingredients: Nevirapine, Nevirapine hemihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 240 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VIRAMUNE 50 mg/5 ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) de 240 ml
- Marketing authorisation holder
- BOEHRINGER INGELHEIM INTERNATIONAL
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 17 Jan 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65501436CIP73521024CIP133400935210241Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NÉVIRAPINE HÉMIHYDRATÉEsuspension | 10,35 mg · 1 ml | SA |
| NÉVIRAPINE ANHYDREsuspension | 10 mg · 1 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.